Key result
ATP and AMPPNP dramatically decrease the apparent Km of endogenous natriuretic peptide receptors A and B for GTP without affecting Vmax, increasing receptor activity over time.
ATP enhances natriuretic peptide receptor activity by reducing the apparent Km for GTP through a phosphorylation-independent mechanism.
May modulate natriuretic peptide signaling in vivo; leaves open relevance to human cardiovascular disease or therapy.
Natriuretic peptide receptors A (NPR-A) and B (NPR-B) mediate most effects of natriuretic peptides by synthesizing cGMP. ATP increases the activity of these receptors by an unknown mechanism. We recently reported that a nonhydrolyzable form of ATP, adenylyl imidodiphosphate (AMPPNP), stabilizes but is not required for the activation of NPR-A and NPR-B in membranes from highly overexpressing cells. Here, we repeated these studies on receptors expressed in endogenous settings. Kinetic analysis indicated that both AMPPNP and ATP dramatically decrease the apparent K(m) of both receptors for GTP but had little effect on the V(max). The EC(50) for AMPPNP decreased as substrate concentration increased whereas the magnitude of the effect was greater at lower GTP concentrations. ATP increased the activity of a mutant receptor containing glutamates substituted for all known phosphorylation sites similarly to the wild-type receptor, consistent with a phosphorylation independent mechanism. Finally, the putative ATP binding sites were investigated. Mutation of the ATP modulatory domain region had no effect, but mutation of K535A dramatically diminished ANP-dependent cyclase activity in a manner that was unresponsive to ATP. Mutation of the highly conserved 630-KSS to AAA (all alanines) resulted in an expressed receptor that had no detectable guanylyl cyclase activity. We conclude that ATP is not required for the initial activation of NPRs but does increase activity over time by reducing the apparent K(m) for GTP.
No takes yet. Share an insight, caveat, or question.
Antos et al. (2007) studied this question. ATP and AMPPNP was evaluated on apparent Km for GTP. ATP and AMPPNP dramatically decrease the apparent Km of endogenous natriuretic peptide receptors A and B for GTP without affecting Vmax, increasing receptor activity over time.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: